Type 2 Diabetes & CV outcomes: more than Glucose management? Lessons from GLP1-ra trials.

11 April 2019 (13:05 - 13:20)

Organised by:

About the speaker

Professor Stephan Jacob

Villingen (Germany)

4 More presentations in this session

Presentation thumbnail

Introduction - The preventive challenge in diabetes & CVD: a multidisciplinary approach.

Professor R. Hobbs (Oxford, GB) Assistant Professor M. Hollander (Amsterdam, NL)

Presentation thumbnail

The cardiovascular challenge for primary care in diabetes.

Professor R. Hobbs (Oxford, GB)

Presentation thumbnail

Targeting CVD in diabetes: novel strategies to tackle the risk.

Professor J. Deanfield (London, GB)

Presentation thumbnail

Panel discussion.

Professor R. Hobbs (Oxford, GB) Professor J. Deanfield (London, GB)

Access the full session

Session thumbnail

The preventive challenge in diabetes & CVD: a multidisciplinary approach.

The Event

EuroPrevent 2019

11 April 2019 13:05 CET

You may be interested in

Congress Session

A multidisciplinary approach to type 2 diabetes, obesity, and cardiovascular diseases: current evidence and a glimpse into the future

27 August 2023

Congress Presentation

Glucose lowering drugs or strategies, major adverse cardiovascular events and heart failure outcomes, and association with weight loss - meta-analysis of large cardiovascular outcome trials

2 September 2019

Congress Presentation

Novel multidisciplinary cardiometabolic clinic in a UK tertiary cardiology centre: early activity, interventions and potential for cardiovascular risk optimisation

27 August 2021

Webinar

Diabetes and ACS - enhancing post-discharge outcomes after primary PCI

26 May 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources